Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biogen Inc (BIIB)

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,107,864
  • Shares Outstanding, K 152,336
  • Annual Sales, $ 13,445 M
  • Annual Income, $ 4,001 M
  • 60-Month Beta 0.44
  • Price/Sales 3.10
  • Price/Cash Flow 7.14
  • Price/Book 3.93
Trade BIIB with:

Options Overview

Details
  • Implied Volatility 41.00%
  • Historical Volatility 27.65%
  • IV Percentile 55%
  • IV Rank 24.59%
  • IV High 122.35% on 11/03/20
  • IV Low 26.06% on 10/06/20
  • Put/Call Vol Ratio 1.11
  • Today's Volume 5,118
  • Volume Avg (30-Day) 3,241
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 64,005
  • Open Int (30-Day) 74,474

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 5.08
  • Number of Estimates 27
  • High Estimate 6.09
  • Low Estimate 4.12
  • Prior Year 9.14
  • Growth Rate Est. (year over year) -44.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.97 +2.53%
on 02/04/21
288.08 -7.12%
on 02/22/21
+4.33 (+1.64%)
since 02/03/21
3-Month
238.40 +12.24%
on 01/04/21
296.38 -9.72%
on 01/29/21
+23.49 (+9.62%)
since 12/03/20
52-Week
223.25 +19.86%
on 11/09/20
363.92 -26.47%
on 11/04/20
-48.20 (-15.26%)
since 03/03/20

Most Recent Stories

More News
Telemedicine and Wellness Apps Have Showcased Tremendous Growth Due To Pandemic

, /PRNewswire/ -- Telemedicine is one of those markets that has actually thrived because of the pandemic. Telemedicine, technicity, is the exchange of medical information from one location to another...

CGN.CN : 0.720 (-12.20%)
CGNSF : 0.6054 (-3.81%)
TDOC : 206.93 (-5.04%)
VEEV : 272.84 (-5.03%)
BIIB : 267.29 (-0.95%)
CDNA : 79.28 (-4.91%)
Denali's (DNLI) Q4 Earnings & Revenues Beat on Biogen Deal

Denali (DNLI) posts earnings in the fourth quarter of 2020 due to collaboration revenues from Biogen.

BIIB : 267.29 (-0.95%)
SNY : 45.58 (-0.78%)
DNLI : 61.68 (-1.97%)
TAK : 17.64 (+2.32%)
Ionis (IONS) Q4 Earnings Decline Y/Y, Sales Beat Estimates

Ionis (IONS) Q4 adjusted earnings decline year over year. The company issues guidance for 2021.

BIIB : 267.29 (-0.95%)
AZN : 47.17 (-1.17%)
PFE : 34.08 (+1.70%)
IONS : 54.00 (-2.35%)
Life Science Cares and Biogen Foundation Help Launch Food For Free's Just Eats Program

- $170,000 grants will fill critical gap for 3,000 food insecure families in Greater Boston via Food For Free's new grocery box program

BIIB : 267.29 (-0.95%)
AbbVie (ABBV) Inks CAR T Deal, Gets Botox Label Expansion Nod

AbbVie (ABBV) signs an agreement to research and develop two new CAR-T cell therapies. The FDA approves label expansion of Botox for pediatric patients.

BIIB : 267.29 (-0.95%)
PFE : 34.08 (+1.70%)
AMGN : 223.68 (-0.89%)
ABBV : 106.44 (-1.31%)
The Zacks Analyst Blog Highlights: Biogen, Gilead Sciences, Regeneron Pharma, Bristol-Myers Squibb and Incyte

The Zacks Analyst Blog Highlights: Biogen, Gilead Sciences, Regeneron Pharma, Bristol-Myers Squibb and Incyte

BIIB : 267.29 (-0.95%)
REGN : 451.96 (-0.64%)
GILD : 63.04 (+0.05%)
INCY : 76.50 (-2.62%)
BMY : 60.30 (-1.58%)
Biogen Announces the Expiration Date Results of Its Cash Tender Offer

Biogen Inc. ("Biogen") (Nasdaq: BIIB) today announced the expiration date results of its previously announced offer to purchase for cash (the "Cash Offer") its outstanding 5.200% Senior Notes due 2045...

BIIB : 267.29 (-0.95%)
Biogen Announces the Expiration Date Results of Its Private Exchange Offer

CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. ("Biogen") (Nasdaq: BIIB) today announced the expiration date results of its previously announced private offer to exchange (the "Exchange...

BIIB : 267.29 (-0.95%)
Biogen and LabCentral Award Two Golden Tickets to Local and Innovative Science Startups

-- Golden Tickets winners Bolden Therapeutics and Seranova Bio will have access to a state-of-the-art lab facilities at LabCentral with mentorship and support from Biogen

BIIB : 267.29 (-0.95%)
Biogen Announces the Pricing Terms of its Cash Tender Offer

Biogen Inc. ("Biogen") (Nasdaq: BIIB) today announced the pricing terms of its previously announced offer to purchase for cash (the "Cash Offer") its outstanding 5.200% Senior Notes due 2045 (the "Notes"),...

BIIB : 267.29 (-0.95%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Business Summary

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia,...

See More

Key Turning Points

3rd Resistance Point 279.97
2nd Resistance Point 277.80
1st Resistance Point 273.83
Last Price 267.29
1st Support Level 267.69
2nd Support Level 265.52
3rd Support Level 261.55

See More

52-Week High 363.92
Fibonacci 61.8% 310.18
Fibonacci 50% 293.59
Fibonacci 38.2% 276.99
Last Price 267.29
52-Week Low 223.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar